UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long‐term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH‐LT study

Alimentary Pharmacology & Therapeutics (Suppl), 2024-02, Vol.59 (4), p.526-534

2024

Volltextzugriff (PDF)

P733 Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel diseases treated with intensified doses: the REMSWITCH-LT study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1374-i1374

2024

Volltextzugriff (PDF)

Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study

Digestive and liver disease, 2024-08, Vol.56 (8), p.1312-1318

2024

Volltextzugriff (PDF)

Modifying the mechanical properties of silk nanofiber scaffold by knitted orientation for regenerative medicine applications

Cellular and molecular biology (Noisy-le-Grand, France), 2016-08, Vol.62 (10), p.16

2016

Volltextzugriff (PDF)

Synthesis and characterization of electrospun polyvinyl alcohol nanofibrous scaffolds modified by blending with chitosan for neural tissue engineering

International journal of nanomedicine, 2012-01, Vol.7 (default), p.25-34

2012

Volltextzugriff (PDF)

P578 CDST (Clinical Decision Support Tool) is predictive of steroid-free clinical remission in patients with Crohn's disease treated with vedolizumab in a specific manner which is mainly driven by the serum level of albumin

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1129-i1129

2024

Volltextzugriff (PDF)

DOP05 Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´s Disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i79-i80

2024

Volltextzugriff (PDF)

P226 Disability in Crohn’s Disease Patients at diagnosis: Findings from the CROCO (Crohn´s Disease Cohort) study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i563-i564

2024

Volltextzugriff (PDF)

LBP-010 - High efficacy and safety of grazoprevir and elbasvir for 8 weeks in treatment-naive, non-severe fibrosis HCV GT1b-infected patients: Interim Results of the STREAGER Study

Journal of hepatology, 2018-04, Vol.68, p.S110-S110

2018

Volltextzugriff (PDF)

High efficacy and safety of grazoprevir and elbasvir for 8 weeks in treatment-naive, non-severe fibrosis HCV GT1b-infected patients: Interim Results of the STREAGER Study

Journal of hepatology, 2018-04, Vol.68, p.S110

2018

Volltextzugriff (PDF)

DOP49 Quantitative proteomics analysis of macrophages from Crohn’s disease patients and infected with adherent-invasive Escherichia coli

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S087-S088

2020

Volltextzugriff (PDF)

The natural history of multiple system atrophy: a prospective European cohort study

Lancet neurology, 2013-03, Vol.12 (3), p.264-274

2013

Volltextzugriff (PDF)

MESSERER (Wilhelm), "Romanische Plastik in Frankreich" (Book Review)

Cahiers de Civilisation Médiévale, 1965, Vol.8, p.215

Dodel, M

1965

Volltextzugriff (PDF)

Therapieansätze zur Behandlung der Demenz bei neurologischen Erkrankungen

Nervenheilkunde, 2010, Vol.29 (11), p.769-772

2010

Volltextzugriff (PDF)

Trajectory Classes of Decline in Health-Related Quality of Life in Parkinson's Disease: A Pilot Study

Value in health, 2011-03, Vol.14 (2), p.329-338

2011

Volltextzugriff (PDF)

Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease

Proceedings of the National Academy of Sciences - PNAS, 2001-12, Vol.98 (25), p.14669-14674

2001

Volltextzugriff (PDF)

Caffeic acid phenethyl ester prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration

Neuroscience, 2011-08, Vol.188, p.135-141

2011

Volltextzugriff (PDF)

Activation of SK2 channels preserves ER Ca²⁺ homeostasis and protects against ER stress-induced cell death

Cell death and differentiation, 2016-05, Vol.23 (5), p.814-827

2016

Volltextzugriff (PDF)

Determinants of societal costs in Alzheimer's disease: GERAS study baseline results

Alzheimer's & dementia, 2015-08, Vol.11 (8), p.933-945

2015

Volltextzugriff (PDF)

Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS

International psychogeriatrics, 2020-02, Vol.32 (2), p.267-277

2020

Volltextzugriff (PDF)

Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation

Neuroscience, 2005, Vol.131 (2), p.513-521

2005

Volltextzugriff (PDF)

Caffeic acid phenethyl ester prevents cerebellar granule neurons (CGNs) against glutamate-induced neurotoxicity

Neuroscience, 2008-09, Vol.155 (4), p.1098-1105

2008

Volltextzugriff (PDF)

Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease

Neurology, 2013-01, Vol.80 (2), p.169-175

2013

Volltextzugriff (PDF)

The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings

Journal of Alzheimer's disease, 2013-01, Vol.36 (2), p.385-399

2013

Volltextzugriff (PDF)

1 – 25 von 275

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(254)
Mit Volltextzugriff
(221)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long‐term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH‐LT study

P733 Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel diseases treated with intensified doses: the REMSWITCH-LT study

Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study

Modifying the mechanical properties of silk nanofiber scaffold by knitted orientation for regenerative medicine applications

Synthesis and characterization of electrospun polyvinyl alcohol nanofibrous scaffolds modified by blending with chitosan for neural tissue engineering

P578 CDST (Clinical Decision Support Tool) is predictive of steroid-free clinical remission in patients with Crohn's disease treated with vedolizumab in a specific manner which is mainly driven by the serum level of albumin

DOP05 Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´s Disease

P226 Disability in Crohn’s Disease Patients at diagnosis: Findings from the CROCO (Crohn´s Disease Cohort) study

LBP-010 - High efficacy and safety of grazoprevir and elbasvir for 8 weeks in treatment-naive, non-severe fibrosis HCV GT1b-infected patients: Interim Results of the STREAGER Study

High efficacy and safety of grazoprevir and elbasvir for 8 weeks in treatment-naive, non-severe fibrosis HCV GT1b-infected patients: Interim Results of the STREAGER Study

DOP49 Quantitative proteomics analysis of macrophages from Crohn’s disease patients and infected with adherent-invasive Escherichia coli

The natural history of multiple system atrophy: a prospective European cohort study

MESSERER (Wilhelm), "Romanische Plastik in Frankreich" (Book Review)

Therapieansätze zur Behandlung der Demenz bei neurologischen Erkrankungen

Trajectory Classes of Decline in Health-Related Quality of Life in Parkinson's Disease: A Pilot Study

Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease

Caffeic acid phenethyl ester prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration

Activation of SK2 channels preserves ER Ca²⁺ homeostasis and protects against ER stress-induced cell death

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

Determinants of societal costs in Alzheimer's disease: GERAS study baseline results

Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS

Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation

Caffeic acid phenethyl ester prevents cerebellar granule neurons (CGNs) against glutamate-induced neurotoxicity

Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease

The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings

Suchergebnisse filtern